These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 37426676)

  • 1. Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy.
    Xiao L; Wang Q; Peng H
    Front Immunol; 2023; 14():1157291. PubMed ID: 37426676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
    Wang Y; Wang D; Yang L; Zhang Y
    Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHISA3 Reprograms Tumor-Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy.
    Zhang S; Yu B; Sheng C; Yao C; Liu Y; Wang J; Zeng Q; Mao Y; Bei J; Zhu B; Chen S
    Adv Sci (Weinh); 2024 Sep; 11(36):e2403019. PubMed ID: 39054639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.
    Kumari N; Choi SH
    J Exp Clin Cancer Res; 2022 Feb; 41(1):68. PubMed ID: 35183252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
    Ren Y; Wang M; Yuan H; Wang Z; Yu L
    Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages.
    Liang Y; He J; Chen X; Yin L; Yuan Q; Zeng Q; Zu X; Shen Y
    Int J Biol Sci; 2023; 19(15):4915-4930. PubMed ID: 37781517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy.
    Baradaran A; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Shadbad MA; Khosravi N; Derakhshani A; Alemohammad H; Afrashteh Nour M; Safarpour H; Silvestris N; Brunetti O; Baradaran B
    Biomed Pharmacother; 2022 Feb; 146():112588. PubMed ID: 35062062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress on Nanomedicine-Mediated Repolarization of Tumor-Associated Macrophages for Cancer Immunotherapy.
    Zhang JY; Su YH; Wang X; Yao X; Du JZ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(5):e2001. PubMed ID: 39425549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
    Mojsilovic SS; Mojsilovic S; Villar VH; Santibanez JF
    Anal Cell Pathol (Amst); 2021; 2021():5523055. PubMed ID: 34476174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
    Li L; Tian Y
    Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy.
    Qiao X; Hu Z; Xiong F; Yang Y; Peng C; Wang D; Li X
    Lipids Health Dis; 2023 Mar; 22(1):45. PubMed ID: 37004014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism in tumour-associated macrophages: a
    Zheng X; Mansouri S; Krager A; Grimminger F; Seeger W; Pullamsetti SS; Wheelock CE; Savai R
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33004525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
    Chen D; Zhang X; Li Z; Zhu B
    Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages in immunotherapy.
    Yan S; Wan G
    FEBS J; 2021 Nov; 288(21):6174-6186. PubMed ID: 33492779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
    Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
    Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
    Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
    Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprograming of tumor-associated macrophages.
    Puthenveetil A; Dubey S
    Ann Transl Med; 2020 Aug; 8(16):1030. PubMed ID: 32953830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells.
    Zhao X; Ren T; Li S; Wang X; Hou R; Guan Z; Liu D; Zheng J; Shi M
    Int J Biol Sci; 2024; 20(13):5109-5126. PubMed ID: 39430253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.